← Insider buys
ITCI

Intra-Cellular Therapies, Inc.

EVP and Chief Commercial Officer Mark Neumann sold $362K of Intra-Cellular Therapies, Inc.

Sold$362,122
$50.01Price
7,241Shares
−13%Stake

What ITCI did after the filing

Prices for ITCI after this filing aren't in yet.

Traded Wed, Mar 1. Filed Fri, Mar 3, 2:03 PM ET, during the session. Not investment advice.